APEIRON CAPITAL Ltd reported 7 positions worth $73.65M for the quarter ended Sep 30, 2026, down 38.6% on the prior quarter. It opened 0 new positions, added to 2, trimmed 2 and exited 6. Its largest holding is On Holding AG at 38.3% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| ABVX Abivax S.A. | -130.6K | -100.0% | $17.40M | Exited |
| SMMT Summit Therapeutics Inc. | -961.9K | -100.0% | $14.01M | Exited |
| NOK Nokia Corp | -378.5K | -100.0% | $5.03M | Exited |
| NKTR Nektar Therapeutics | -55.0K | -51.7% | $3.84M | 4.87% |
| SNDK Sandisk Corp | -1,580 | -100.0% | $3.59M | Exited |
| LITE Lumentum Holdings Inc. | -3,500 | -100.0% | $3.00M | Exited |
| TCOM Trip.com Group Ltd | -61.1K | -87.2% | $2.43M | 0.483% |
| POET Poet Technologies Inc. | -142.0K | -100.0% | $1.46M | Exited |
No new positions this quarter.
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| ABVX Abivax S.A. | -130.6K | $17.40M | 14.5% |
| SMMT Summit Therapeutics Inc. | -961.9K | $14.01M | 11.68% |
| NOK Nokia Corp | -378.5K | $5.03M | 4.19% |
| SNDK Sandisk Corp | -1,580 | $3.59M | 2.99% |
| LITE Lumentum Holdings Inc. | -3,500 | $3.00M | 2.5% |
| POET Poet Technologies Inc. | -142.0K | $1.46M | 1.22% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ONON On Holding AG | Consumer Discretionary | 795.9K | $28.19M | 38.27% | 0 | 0.0% | Unchanged | 0.13% |
| 2 | QFIN Qfin Holdings, Inc. | Technology | 976.2K | $14.63M | 19.86% | 0 | 0.0% | Unchanged | 0.8% |
| 3 | WDC Western Digital Corp | Technology | 18.0K | $11.49M | 15.6% | +5,000 | +38.5% | Added | 0% |
| 4 | TSM Taiwan Semiconductor Manufacturing Co Ltd | Technology | 22.2K | $10.57M | 14.36% | +4,300 | +24.0% | Added | 0% |
| 5 | STX Seagate Technology Holdings plc | Technology | 5,000 | $4.82M | 6.55% | 0 | 0.0% | Unchanged | 0% |
| 6 | NKTR Nektar Therapeutics | Healthcare | 51.4K | $3.59M | 4.87% | -55.0K | -51.7% | Reduced | 0.16% |
| 7 | TCOM Trip.com Group Ltd | Consumer Discretionary | 8,936 | $356.01K | 0.483% | -61.1K | -87.2% | Reduced | 0% |
Tip. Select a row to see that position’s full history at Apeiron Capital.
As of its Q3 2026 13F filing, APEIRON CAPITAL Ltd’s five largest positions were On Holding AG (ONON) at 38.3%, Qfin Holdings, Inc. (QFIN) at 19.9%, Western Digital Corp (WDC) at 15.6%, Taiwan Semiconductor Manufacturing Co Ltd (TSM) at 14.4%, Seagate Technology Holdings plc (STX) at 6.5% of the reported portfolio.
APEIRON CAPITAL Ltd reported a 13F portfolio worth $73.65M across 7 positions for Q3 2026. That is down 38.6% from the previous quarter.
Its largest purchases by value were Western Digital Corp ($3.19M), Taiwan Semiconductor Manufacturing Co Ltd ($2.05M). It opened 0 new positions.
Its largest sales by value were Abivax S.A. ($17.40M), Summit Therapeutics Inc. ($14.01M), Nokia Corp ($5.03M). It exited 6 positions entirely.
From the Form 13F-HR reports APEIRON CAPITAL Ltd files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.